These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 21383310)

  • 1. Determination of the exact molecular requirements for type 1 angiotensin receptor epidermal growth factor receptor transactivation and cardiomyocyte hypertrophy.
    Smith NJ; Chan HW; Qian H; Bourne AM; Hannan KM; Warner FJ; Ritchie RH; Pearson RB; Hannan RD; Thomas WG
    Hypertension; 2011 May; 57(5):973-80. PubMed ID: 21383310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Src is required for mechanical stretch-induced cardiomyocyte hypertrophy through angiotensin II type 1 receptor-dependent β-arrestin2 pathways.
    Wang S; Gong H; Jiang G; Ye Y; Wu J; You J; Zhang G; Sun A; Komuro I; Ge J; Zou Y
    PLoS One; 2014; 9(4):e92926. PubMed ID: 24699426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Independent beta-arrestin2 and Gq/protein kinase Czeta pathways for ERK stimulated by angiotensin type 1A receptors in vascular smooth muscle cells converge on transactivation of the epidermal growth factor receptor.
    Kim J; Ahn S; Rajagopal K; Lefkowitz RJ
    J Biol Chem; 2009 May; 284(18):11953-62. PubMed ID: 19254952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beta-arrestin2-mediated inotropic effects of the angiotensin II type 1A receptor in isolated cardiac myocytes.
    Rajagopal K; Whalen EJ; Violin JD; Stiber JA; Rosenberg PB; Premont RT; Coffman TM; Rockman HA; Lefkowitz RJ
    Proc Natl Acad Sci U S A; 2006 Oct; 103(44):16284-9. PubMed ID: 17060617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An angiotensin II type 1 receptor mutant lacking epidermal growth factor receptor transactivation does not induce angiotensin II-mediated cardiac hypertrophy.
    Zhai P; Galeotti J; Liu J; Holle E; Yu X; Wagner T; Sadoshima J
    Circ Res; 2006 Sep; 99(5):528-36. PubMed ID: 16902180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ADAM17 mediates epidermal growth factor receptor transactivation and vascular smooth muscle cell hypertrophy induced by angiotensin II.
    Ohtsu H; Dempsey PJ; Frank GD; Brailoiu E; Higuchi S; Suzuki H; Nakashima H; Eguchi K; Eguchi S
    Arterioscler Thromb Vasc Biol; 2006 Sep; 26(9):e133-7. PubMed ID: 16840716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Klotho inhibits angiotensin II-induced cardiomyocyte hypertrophy through suppression of the AT1R/beta catenin pathway.
    Yu L; Meng W; Ding J; Cheng M
    Biochem Biophys Res Commun; 2016 Apr; 473(2):455-61. PubMed ID: 26970306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The angiotensin II type 2 receptor causes constitutive growth of cardiomyocytes and does not antagonize angiotensin II type 1 receptor-mediated hypertrophy.
    D'Amore A; Black MJ; Thomas WG
    Hypertension; 2005 Dec; 46(6):1347-54. PubMed ID: 16286564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential pathways of angiotensin II-induced extracellularly regulated kinase 1/2 phosphorylation in specific cell types: role of heparin-binding epidermal growth factor.
    Shah BH; Yesilkaya A; Olivares-Reyes JA; Chen HD; Hunyady L; Catt KJ
    Mol Endocrinol; 2004 Aug; 18(8):2035-48. PubMed ID: 15143154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin II type 2 receptor antagonizes angiotensin II type 1 receptor-mediated cardiomyocyte autophagy.
    Porrello ER; D'Amore A; Curl CL; Allen AM; Harrap SB; Thomas WG; Delbridge LM
    Hypertension; 2009 Jun; 53(6):1032-40. PubMed ID: 19433781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Death receptor 5 contributes to cardiomyocyte hypertrophy through epidermal growth factor receptor transactivation.
    Tanner MA; Thomas TP; Grisanti LA
    J Mol Cell Cardiol; 2019 Nov; 136():1-14. PubMed ID: 31473246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biased signaling of the angiotensin II type 1 receptor can be mediated through distinct mechanisms.
    Bonde MM; Hansen JT; Sanni SJ; Haunsø S; Gammeltoft S; Lyngsø C; Hansen JL
    PLoS One; 2010 Nov; 5(11):e14135. PubMed ID: 21152433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selectively engaging β-arrestins at the angiotensin II type 1 receptor reduces blood pressure and increases cardiac performance.
    Violin JD; DeWire SM; Yamashita D; Rominger DH; Nguyen L; Schiller K; Whalen EJ; Gowen M; Lark MW
    J Pharmacol Exp Ther; 2010 Dec; 335(3):572-9. PubMed ID: 20801892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Obestatin stimulates Akt signalling in gastric cancer cells through beta-arrestin-mediated epidermal growth factor receptor transactivation.
    Alvarez CJ; Lodeiro M; Theodoropoulou M; Camiña JP; Casanueva FF; Pazos Y
    Endocr Relat Cancer; 2009 Jun; 16(2):599-611. PubMed ID: 19153210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The novel angiotensin II type 1 receptor (AT1R)-associated protein ATRAP downregulates AT1R and ameliorates cardiomyocyte hypertrophy.
    Tanaka Y; Tamura K; Koide Y; Sakai M; Tsurumi Y; Noda Y; Umemura M; Ishigami T; Uchino K; Kimura K; Horiuchi M; Umemura S
    FEBS Lett; 2005 Mar; 579(7):1579-86. PubMed ID: 15757644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urotensin II induces rat cardiomyocyte hypertrophy via the transient oxidization of Src homology 2-containing tyrosine phosphatase and transactivation of epidermal growth factor receptor.
    Liu JC; Chen CH; Chen JJ; Cheng TH
    Mol Pharmacol; 2009 Dec; 76(6):1186-95. PubMed ID: 19755521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endocytosis machinery is required for beta1-adrenergic receptor-induced hypertrophy in neonatal rat cardiac myocytes.
    Morisco C; Marrone C; Galeotti J; Shao D; Vatner DE; Vatner SF; Sadoshima J
    Cardiovasc Res; 2008 Apr; 78(1):36-44. PubMed ID: 18194989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A protein tyrosine phosphatase inhibitor, pervanadate, inhibits angiotensin II-Induced beta-arrestin cleavage.
    Jang SH; Hwang SA; Kim M; Yun SH; Kim MS; Karnik SS; Lee C
    Mol Cells; 2009 Jul; 28(1):25-30. PubMed ID: 19711041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urotensin II promotes hypertrophy of cardiac myocytes via mitogen-activated protein kinases.
    Onan D; Pipolo L; Yang E; Hannan RD; Thomas WG
    Mol Endocrinol; 2004 Sep; 18(9):2344-54. PubMed ID: 15205471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beta-arrestin 2 mediates cardiac hypertrophy induced by thyroid hormones via AT1R.
    Lino CA; de Bortoli Teixeira L; Capelupe Simões S; de Oliveira Silva T; Diniz GP; da Costa-Neto CM; Barreto-Chaves MLM
    J Cell Physiol; 2021 Jun; 236(6):4640-4654. PubMed ID: 33345322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.